10 - 12 July 2021
EAACI Hybrid Congress 2021

Industry Section

Sponsors and Exhibitors

Our industry sponsors are at the core of the research and development that contributes to the improvement of patient care. They provide the essential data on products and resources to enable physicians in daily practice and improve patient outcomes.

EAACI’s transition from a fully digital annual congress to a Hybrid congress will provide sponsors and exhibitors further unique opportunities to reach the EAACI community worldwide. The very latest developments will be presented, discussed and debated during the EAACI Hybrid Congress 2021.

For more information on the sponsor opportunities visit our EAACI Sponsor Online Platform (ESOP)

For further sponsor information, please visit our Industry Service Centre 

Ensure you are at the forefront of research, and support Allergy and Immunology development by sharing Industry activities and attending the following:

Industry Symposia

Delegates are invited to attend a series of Industry Symposia included in the scientific programme of the Congress. All symposia and workshops offer relevant data on up-to-date scientific information and developments from the Industry.

More details on Industry Programmes will be available soon on this page.

RFH 3540 website


Join us in meeting with key industry experts, exchange knowledge on critical areas of development and research
in allergy and immunology.

The onsite and virtual exhibitions will be open according to the main scientific programme timetable, subject to final adjustments.

  • Virtual Exhibition – open from 10 July 2021 until 10 January 2022
  • Start of onsite Exhibition: 10 July 2021 – 9:00 (CET)
  • End of onsite Exhibition: 12 July 2021 – 17:30 (CET)
RFH 2513 website

Industry hands-on workshops
Delegates can attend hands-on learning workshops from clinical and/or technical experts on specific areas of expertise, allowing you to

address specific issues that are essential to your daily practice.

In some cases, these workshops will also be broadcast to a live digital audience.

RFH 2258 website


EAACI Mobile App
Company & Product Descriptions available in the EAACI Events mobile app.

The EAACI smartphone app enables you to explore the EAACI Hybrid Congress 2021 programme and exhibition at your fingertips.

Download now through the QR Code below and stay tuned for more information to come.
EAACI2021 MobileApp QR code

EAACI Hybrid Congress 2021 current list of exhibitors and sponsors:

American Academy of Allergy, Asthma & Immunology (AAAAI)
Abbott Labratories
Aimmune Therapeutics
ALK - Abelló
Allergy Therapeutics
AstraZeneca PLC
BioCryst Pharmaceuticals
Bristol Myers Sqiubb
BluePrint Medicines
CSL Behring
DBV Technologies
European Respiratory Society (ERS)
GlaxoSmithKline plc
HAL Allergy
LETI Pharma
MacroArray Diagnostics
Nestlé Health Science
Nestle Purina PetCare
OM Pharma
Orion Pharma
Pharming Group NV
Polish Society of Allergology (PTA)
Revenio Research Oy
Sanofi Genzyme / Regeneron
Thermo Fisher Scientific
World Allergy Organziation

We are happy to assist companies in selecting the various Industry options at the EAACI Hybrid Congress 2021. Please contact us at sponsors@eaaci.org to discuss the various options available.
Privacy Policy - disclaimer

EAACI recently updated its privacy policy and would like to highlight some key bits of information with you.

  • EAACI does not distribute, share or sell your information;
  • For technical and administrative purposes some information that can be used to identify you may be forwarded to third parties. For example, to process your registration for the EAACI Annual Congress and other EAACI events;
  • The Academy may also send you e-mail messages with news from the society. If you would like to no longer receive them, you can unsubscribe at any time by using the unsubscribe link in any of our communications;
  • You may also update your preferences or your profile information at any time by contacting us.

To continue please confirm that you agree with our updated privacy policy.

Thank you!

You have successfully agreed the new privacy policy – disclaimer.

Thank you!

You disagreed with the new privacy policy – disclaimer and your feedback will be reviewed as soon as possible.

Agree & Continue
Send feedback